Lv11
60 积分 2025-03-31 加入
The Efficacy and Safety of Divozilimab in Patient with Systemic Sclerosis: 48-Week Results of the Randomized Double-Blind Placebo-Controlled Phase III Clinical Study LIBERIUS
3小时前
已关闭
Stem cells therapies for liver diseases: for current practice and future goals
29天前
已完结
Pathogenesis of vasculopathy in systemic sclerosis and its contribution to fibrosis
1个月前
已完结
Resetting autoimmune disease with CAR cell therapies
1个月前
已完结
Senescent CD4+ T cells and autoimmune diseases: mechanisms and therapeutic prospects
2个月前
已完结
Research advance in mesenchymal stem cell-based therapy for diabetic nephropathy
2个月前
已完结
Combination therapy for kidney disease in people with diabetes mellitus
2个月前
已完结
Universal Base-Edited CAR7 T Cells for T-Cell Acute Lymphoblastic Leukemia
3个月前
已完结
Administration of Autologous Mesenchymal Cells for the Treatment of Arthritis
3个月前
已完结
Safety and preliminary efficacy of allogeneic bone marrow-derived multipotent mesenchymal stromal cells for systemic sclerosis: a single-centre, open-label, dose-escalation, proof-of-concept, phase 1/2 study
3个月前
已完结
皖公网安备34019202002308
